Moligo Technologies

📍 Solna, Sweden🗓 Founded 2019👥 8 employees💰 Last funded Feb 2019
Biotechnology Research🌐 moligotechnologies.com
Website LinkedIn
We developed a new technology for enzymatic production of high quality, long and even functionalized DNA molecules, which will have a huge impact on industrial synthetic biology, precision diagnostics, therapeutics and nanotechnology. DNA oligonucleotides are commonly synthesized by solid phase, but after decades of fine-tuning and improvements in liquid handling, the upper limit of phosphoramidite-based oligo synthesis is now about 200-300 nucleotides, with further limitations in terms of purity and efficacy in presence of strong secondary structures or repeats. The advances and improvements in diagnostic and therapeutic systems based on nucleic acids are leading to a big and urgent need of highly pure and long DNA strands, and Moligo Technologies mission is to satisfy this necessity. In fact, thanks to our know-how, and to the capacity of experienced scientific and executive team, we are already able to synthesize, and very soon commercialize, single stranded oligonucleotides of thousands of bases with purity of about 99.9%.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Moligo Technologies?
Moligo Technologies has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Moligo Technologies last raise funding?
The most recent investment in Moligo Technologies recorded on gritt.io was in February 2019.
When was Moligo Technologies founded?
Moligo Technologies was founded in 2019.
What industry is Moligo Technologies in?
Moligo Technologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Moligo Technologies based?
Moligo Technologies is headquartered in Solna, Sweden.